Table 6.
IBD98-M 0.8 g/day (N = 12) | IBD98-M 1.2 g/day (N = 14) | Placebo (N = 14) | |
---|---|---|---|
Endoscopic score at baseline | |||
n | 12 | 14 | 14 |
Median (range) | 2.00 (1–3) | 2.00 (1–3) | 2.00 (1–3) |
Endoscopic score at visit 6 | |||
n | 12 | 14 | 14 |
Median (range) | 1.50 (0-3) | 2.00 (0–3) | 2.00 (0–3) |
Endoscopic score at visit 6 – baseline | T | ||
n | 12 | 14 | 14 |
Median | 0.00 (−2–0) | 0.00 (−1–1) | 0.00 (−2–1) |
p value * | 0.133 | 0.832 |
*p value comparing treatment groups (IBD98 vs. Placebo) using ANCOVA. Since the population was small, and the distribution was not normal, the median was used to show the changes in the endoscopic subscore.